Behind Trump’s 100% Tariffs: China’s New Drugs That Cannot Be Contained

Apr 02,2026

US Imposes Tariffs, China Seeks Premiums

China’s Innovative Drugs Going Global: From “Annual Boom” to “Quarterly Surge”

Apr 01,2026

Q1 2026 Panorama Review: China Innovative Drug BD

Wall Street Capital Targets China’s Biotech Sector

Mar 31,2026

Renowned VC Firm RA Capital Launches a SPAC

NewCo Reaches Monetization Moment

Mar 31,2026

Hengrui Medicine-Backed NewCo Launches IPO

CPIC 2026 | Junlian Capital & Rxilient Special Session: Global Expansion of Pharmaceutical Companies and Collaboration in Emerging Markets

Mar 29,2026

Legend Capital, Rxilient, and TONACEA are jointly hosting a special session themed "Global Development of Pharmaceutical Enterprises and Emerging Market Collaboration." The session will focus on the latest policies, market opportunities and challenges, product and industry go-to-market strategies, and localization practices in Southeast Asia, the Middle East and North Africa, and Latin America.

AI-Driven Drug Discovery Ushers in “China’s Moment”

Mar 28,2026

Standing in the spotlight, waiting
< 1...11121314 > proceed page